Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Synthetic Biologists Create Interlinked Microbial Populations

By LabMedica International staff writers
Posted on 09 Sep 2015
A team of synthetic biologists has demonstrated a method for controlling how populations of microbial cells interact and regulate each other.

A challenge of synthetic biology is the creation of cooperative microbial systems that exhibit population-level behaviors. More...
Such systems use cellular signaling mechanisms to regulate gene expression across multiple cell types.

In an attempt to create such a system artificially, investigators at Rice University (Houston, TX, USA) constructed a synthetic microbial consortium from genetically engineered populations of E. coli that comprised two distinct cell types—an “activator” strain and a “repressor” strain. The activator strain upregulated the expression of targeted genes while the repressor strain downregulated the same genes. The bacteria, which were grown in microfluidic culture devices, had been engineered to synthesize fluorescent reporter genes so their activities could be monitored.

Results published in the August 28, 2015, issue of the journal Science revealed that the strains produced two orthogonal cell-signaling molecules that regulated gene expression within a synthetic circuit spanning both strains. Of particular interest was the observation that the two strains generated emergent, population-level oscillations only when cultured together.

"The main push in synthetic biology has been to engineer single cells," said senior author Dr. Matthew R. Bennett, assistant professor of biochemistry and cell biology at Rice University. "But now we are moving toward multicellular systems. We want cells to coordinate their behaviors in order to elicit a populational response, just the way our bodies do. We have many different types of cells in our bodies, from skin cells to liver cells to pancreatic cells, and they all coordinate their behaviors to make us work properly. To do this, they often send out small signaling molecules that are produced in one cell type and effect change in another cell type. We take that principle and engineer it into these very simple organisms to see if we can understand and build multicellular systems from the ground up."

Related Links:

Rice University



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.